Karuna Therapeutics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Karuna Therapeutics last-minute Real Value cannot be determined due to lack of data. The latest price of Karuna Therapeutics is $0.0. Our model forecasts the value of Karuna Therapeutics from analyzing the firm fundamentals such as Operating Margin of (755.64) %, shares outstanding of 38.2 M, and Return On Equity of -0.36 as well as examining its technical indicators and probability of bankruptcy.
Karuna Therapeutics Total Value Analysis
Karuna Therapeutics is now anticipated to have valuation of 11.35 B with market capitalization of 12.6 B, debt of 16.69 M, and cash on hands of 407.41 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Karuna Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.35 B | 12.6 B | 16.69 M | 407.41 M |
Karuna Therapeutics Investor Information
About 86.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.46. Karuna Therapeutics recorded a loss per share of 11.74. The entity had not issued any dividends in recent years. Based on the key indicators related to Karuna Therapeutics' liquidity, profitability, solvency, and operating efficiency, Karuna Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Karuna Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Karuna Therapeutics has an asset utilization ratio of 0.0489 percent. This suggests that the Company is making $4.89E-4 for each dollar of assets. An increasing asset utilization means that Karuna Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Karuna Therapeutics Ownership Allocation
Karuna Therapeutics maintains a total of 38.2 Million outstanding shares. The majority of Karuna Therapeutics outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Karuna Therapeutics to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Karuna Therapeutics. Please pay attention to any change in the institutional holdings of Karuna Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Karuna Therapeutics Profitability Analysis
The company reported the previous year's revenue of 654 K. Net Loss for the year was (433.68 M) with profit before overhead, payroll, taxes, and interest of 10.64 M.Karuna Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 37 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Karuna Stock
If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |